XtalPi, which uses AI for drug discovery and development, raises $400M Series D led by OrbiMed and RRJ, at a valuation of over $2B (KrASIA)

KrASIA:
XtalPi, which uses AI for drug discovery and development, raises $400M Series D led by OrbiMed and RRJ, at a valuation of over $2B  —  The company provides its AI technology to pharmaceutical companies to enhance R&D for new drugs.  —  AI pharmaceutical company XtalPi secured USD 400 million …